Sort
30,917 grants matching “tumor microenvironment”
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
$734,126Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M
$733,309Anil K Rustgi · University Of Pennsylvania · P01 · FY2011 · CA
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$733,308Mark Yarchoan · Johns Hopkins University · R01 · FY2022 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity
$733,069Hao Wu · Boston Children'S Hospital · R01 · FY2024 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity
$733,069Hao Wu · Boston Children'S Hospital · R01 · FY2025 · CA
BONE MARROW MICROENVIRONMENT AND NEUROBLASTOMA PROGRESSION
$732,590Yves Declerck · Children'S Hospital Of Los Angeles · P01 · FY2012 · CA
Clinical Implications of Natural Killer-derived exosomal miRNAs in Neuroblastoma
$732,471Muller Fabbri · Children'S Research Institute · R01 · FY2025 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$732,152Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2021 · CA
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
$732,134Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2022 · DK
Exploring PSMA Biology in Tumor neovasculature
$731,830Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Exploring PSMA Biology in Tumor neovasculature
$731,830Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
$731,547Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2020 · CA
Inflammation, Macrophage Differentiation, and Cancer
$731,310Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Protease/PAR2/TRPV4 Axis and Oral Cancer Pain
$731,251Brian L Schmidt · New York University · R01 · FY2020 · DE
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
$731,128Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
(PQC4) Habitats in Prostate Cancer
$730,977Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
NexTGen - STANFORD
$730,473Irving Lerner Weissman · Stanford University · OT2 · FY2022 · CA
A novel preclinical model of spontaneous metastasis
$730,435Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
ULK Inhibition Rewires Tumor and Immune Cell Metabolism
$730,407Jeffrey Paul Mackeigan · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
Leveraging Radiation-Induced Senescence and PTPN2 Inhibition to Enhance Immune-Mediated Tumor Control in Rectal Cancer
$730,398Paul Bernard Romesser · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Inflammatory Signaling in the Leptomeninges
$730,398Adrienne A. Boire · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$730,332Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Integrating systems immunology with immunometabolism and cancer immunity
$730,271Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2021 · CA
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
$730,063Dean W Felsher · Stanford University · R01 · FY2018 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$730,001Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2020 · CA